Evaluation of Efficacy and Safety of Etanercept Therapy in Patients with Early and Late Juvenile Idiopathic Arthritis without Systemic Manifestations

• Main Authors: T. M. Bzarova (Author), E. I. Alexeeva (Author), S. I. Valieva (Author), R. V. Denisova (Author), K. B. Isaeva (Author), E. G. Chistyakova (Author), A. M. Chomakhidze (Author), T. V. Sleptsova (Author), A. N. Fetisova (Author), N. I. Taibulatov (Author)
• Format: Book
• Published: "Paediatrician" Publishers LLC, 2015-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: An issue related to the terms of assignment of genetically engineered biological agents to patients with juvenile idiopathic arthritis (JIA) still remains debatable in pediatric rheumatology.Objective: Our aim was to evaluate the efficacy and safety of etanercept therapy in early and lat...